Basit öğe kaydını göster

dc.contributor.authorOzkirimli, S
dc.contributor.authorCesur, N
dc.contributor.authorApak, TI
dc.contributor.authorAboul-Enein, HY
dc.date.accessioned2021-03-03T14:58:34Z
dc.date.available2021-03-03T14:58:34Z
dc.identifier.citationCesur N., Apak T., Aboul-Enein H., Ozkirimli S., "LC determination of amino glutethimide enantiomers as dansyl and fluorescamine derivatives in tablet formulations", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, cilt.28, ss.487-492, 2002
dc.identifier.issn0731-7085
dc.identifier.othervv_1032021
dc.identifier.otherav_3c850da4-6b6d-4dab-b738-19902ff8db1d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/44599
dc.identifier.urihttps://doi.org/10.1016/s0731-7085(01)00675-6
dc.description.abstractDetermination of dansyl (AG-DNS) and fluorescamine (AG-F) derivatives of rac-aminoglutethimide in tablet formulation by HPLC has been achieved on a cellulose tris-(3,5-dimethylphenyl carbamate), known as Chiralcel OD and OD-R under normal and reversed phase columns, respectively, using a fluorescence detector (lambda(ex), 360 nm; lambda(em), 530 nm for AG-DNS derivatives; lambda(ex), 395 nm; lambda(em), 495 nm for fluorescamine derivatives (AG-F)). The best results were obtained with mobile phase ethanol:cyclohexane:methanol (95:5:2 v/v/v) for AG-DNS derivatives and acetonitrile:0.5% ortho-phosphoric acid (85:15 v/v) containing 0.26 mM 1-hexanesulfonic acid sodium salt (HSA) for AG-F, respectively. The lower limit of detection (signal to noise ratio of 3:1) were found to be 20 ng ml(-1) for each enantiomer for AG-DNS and 20.5 ng ml(-1) for each diastreoisomer for AG-F. (C) 2002 Elsevier Science B.V. All rights reserved.
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectKİMYA, ANALİTİK
dc.subjectKimya
dc.subjectTemel Bilimler (SCI)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectAnalitik Kimya
dc.subjectTemel Bilimler
dc.titleLC determination of amino glutethimide enantiomers as dansyl and fluorescamine derivatives in tablet formulations
dc.typeMakale
dc.relation.journalJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
dc.contributor.department, ,
dc.identifier.volume28
dc.identifier.startpage487
dc.identifier.endpage492
dc.contributor.firstauthorID165058


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster